Fund Evaluation Group »

Aziyo Biologics shares owned by Fund Evaluation Group

Quarter-by-quarter ownership of Aziyo Biologics (ELUT) shares owned by Fund Evaluation Group from 13F filings

Historical chart of Fund Evaluation Group investment in Aziyo Biologics

Tip: Access up to 7 years of quarterly data

All positions including Aziyo Biologics held by Fund Evaluation Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aziyo Biologics by Fund Evaluation Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $13k 13k 1.05

More positions owned by Fund Evaluation Group

iShares Core S&P 500 ETF Etf (IVV)
iShares US Treasury Bond ETF Etf (GOVT)
Schwab U.S. Large-Cap Growth ETF Etf (SCHG)
Schwab U.s. Large-cap Etf Etf (SCHX)
Ishares Core Msci Total International Stock Etf Etf (IXUS)
Schwab International Equity ETF Etf (SCHF)
Vanguard S&p 500 Etf Etf (VOO)
Vanguard Total Stock Market Etf Etf (VTI)
Vanguard Short-term Inflation-protected Securities Etf Etf (VTIP)
S&P500 Catholic Values ETF Etf (CATH)
Schwab Emerging Markets Equity Etf Etf (SCHE)
Tcw Transform 500 Etf Etf (VOTE)
iShares Core US Aggregate Bond ETF Etf (AGG)
Ishares Trust Ishares 0-1 Year Treasury Bond Etf Etf (SHV)
Vanguard Russell 3000 Etf Etf (VTHR)

View all positions for Fund Evaluation Group

Top funds holding Aziyo Biologics

AIGH Capital Management
Nantahala Capital Management
Silverarc Capital Management
Knollwood Investment Advisory
Vanguard Group
Vanguard Capital Management
Perkins Capital Management
Geode Capital Management
CI Private Wealth
Birchview Capital
BlackRock
Rossmore Private Capital
Vanguard Fiduciary Trust
Citadel Advisors
XTX Topco

View all funds holding Aziyo Biologics